=
=
5-Acetyl-3-(4-methylphenyl)-1,3,4-thiadiazol-2(3H)-one 7b
156.2 (C-5), 188.9 (C(2) S), 189.1 (Me–C O); HRMS (EI):
found 250.021512 (M+), C11H10N2OS2 requires 250.023442; m/z
(EI): 250 (M+, 26%), 207 (2), 174 (3), 149 (86), 148 (30), 132 (32),
105 (65) and 91 (100).
This compound was prepared from 6b (2.8 g, 10 mmol) and
1,1ꢀ-carbonyldiimidazole (2.0 g, 12.5 mmol) by following the
same procedure described above for 7a. Yield 1.5 g (64%);
mp 87–88 ◦C (ethanol); found C, 56.28; H, 3.21; N, 11.75; S,
13.44%. C11H10N2O2S requires C, 56.40; H, 4.30; N, 11.96; S,
13.68%; mmax(KBr)/cm−1 3100, 3023, 2914, 2849, 1693 br, 1609,
1524, 1508, 1452, 1365, 1274, 1153, 1087 and 1059;1H- NMR
5-Acetyl-3-(4-chlorophenyl)-1,3,4-thiadiazol-2(3H)-thione 8c
This compound was prepared from 6c (3.0 g, 10 mmol) and
1,1ꢀ-thiocarbonyldiimidazole (2.2 g, 12.5 mmol) by following
the same procedure described above for 8a. Yield 1.84 g (68%);
(300 MHz, DMSO-d6): d 2.32 (s, 3H, Ar–CH3ꢀ), 2.52 (s, 3H,
◦
ꢀ
=
CH3–C O), 7.32 (d, J = 7.4 Hz, 2H, H-3 / H-5 ), 7.59 (d, J =
mp 122–123 C; found C, 44.12; H, 2.52; N, 10.13; S, 23.51%.
7.4 Hz, 2H, H-2ꢀ/H-6ꢀ);13C-NMR (75 MHz, DMSO-d6): d 21.2
(Ar–CH3), 25.1 (CH3–CO), 123.2 (C-2ꢀ/C-6ꢀ), 130.2 (C-3ꢀ/C-
C10H7ClN2OS2 requires C, 44.36; H, 2.61; N, 10.35; S, 23.68%;
mmax(KBr)/cm−1 3094, 3061, 2965, 2914, 2850, 1692, 1500,
1
5ꢀ), 134.2 (C-4ꢀ), 138.4 (C-1ꢀ), 150.3 (C-5), 169.0 (C-2), 190.4
1484, 1367, 1333, 1280, 1205, 1091, 1053 and 1015; H-NMR
+
=
(Me–C O); HRMS (EI): found 234.046179 (M ), C11H10N2O2S
(300 MHz, DMSO-d6): d 2.53 (s, 3H, CH3), 7.65 (d, J = 8.4 Hz,
2H, H-3ꢀ/H-5ꢀ), 7.75 (d, J = 8.4 Hz, 2H, H-2ꢀ/ H-6ꢀ); 13C-
NMR (75 MHz, DMSO-d6): d 26.0 (CH3), 128.8 (C-2ꢀ/C-6ꢀ),
129.9 (C-3ꢀ/C-5ꢀ), 134.8 (C-4ꢀ), 137.1 (C-1ꢀ), 156.5 (C-5), 189.0
requires 234.046281; m/z (EI): 234 (M+, 24%), 174 (16), 132 (64),
105 (100), 104 (23) and 91 (11).
=
=
5-Acetyl-3-(4-chlorophenyl)-1,3,4-thiadiazol-2(3H)-one 7c
(C(2) S), 189.1 (Me–C O); HRMS (EI): found 269.968284
(M+), C10H7ClN2OS2 requires 269.968816; m/z (EI): 270 (M+,
69%), 227 (1), 194 (10), 169 (100), 152 (71), 125 (65), 111 (42)
and 90 (12).
This compound was prepared from 6c (3.0 g, 10 mmol) and
1,1ꢀ-carbonyldiimidazole (2.0 g, 12.5 mmol) by following the
same procedure described above for 7a. Yield 1.6 g (63%); mp
102–103 ◦C (CHCl3–pet. ether); found C, 46.92; H, 2.58; N,
10.87; S, 12.44%. C10H7ClN2O2S requires C, 47.16; H, 2.77; N,
11.00; S, 12.59%; mmax(KBr)/cm−1 3094, 2914, 1692, 1525, 1486,
1371, 1268, 1146 and 1088;1H-NMR (300 MHz, DMSO-d6): d
2.45 (s, 3H, CH3), 7.58 (d, J = 8.0 Hz, 2H, H-3ꢀ/H-5ꢀ), 7.63
(d, J = 8.0 Hz, 2H, H-2ꢀ/H-6ꢀ); 13C-NMR (75 MHz, DMSO-
d6): d 25.0 (CH3), 124.6 (C-2ꢀ/C-6ꢀ), 129.4 (C-3ꢀ/C-5ꢀ), 132.8
Collection of X-ray diffraction data and structure analysis of 7b
Yellow block crystals were grown by allowing a clear solution of
7b in hot ethanol to evaporate slowly at rt such that its volume
was reduced by about 20% over 2–3 days. Crystal data collection
was made with a Siemens SMART CCD diffractometer [Mo–
Ka-radiation, graphite monochromator] operating in the omega
scan mode (0.3◦). The data were reduced with the Siemens-
Bruker program suite XSCANS13 and the structure was solved
by the direct method using SHELXTL PLUS programs.14 All
non-hydrogen atoms were refined anisotropically by full-matrix,
least-squares procedure based on F2 using all unique data.
ꢀ
ꢀ
=
(C-4 ), 136.1 (C-1 ), 150.8 (C-5), 169.0 (C-2), 190.4 (Me–C O);
HRMS (EI): found 253.990925 (M+), C10H7ClN2O2S requires
253.991655; m/z (EI): 254 (M+, 33%), 194 (29), 152 (88), 125
(100) and 90 (24).
5-Acetyl-3-phenyl-1,3,4-thiadiazol-2(3H)-thione 8a
Crystal structure determination of 7b
To a mixture of 1,1ꢀ-thiocarbonyldiimidazole (2.2 g, 12.5 mmol)
and compound 6a (2.7 g, 10 mmol) was added dry tetrahy-
drofuran (50 cm3) and the resulting solution was stirred at rt
for 4–5 h. The solvent was then removed in vacuo, the residue
was immediately treated with water (40 cm3) and extracted
with chloroform (2 × 40 cm3) The combined organic extracts
were dried (Na2SO4), the solvent was evaporated and the
residual solid product was purified by column chromatography
(silica gel), using dichloromethane as eluent, to afford the title
compound 8a as yellow solid. Yield 1.51 g (64%); mp 117–118 ◦C;
found 50.64; H, 3.28; N, 11.74; S, 27.02%. C10H8N2OS2 requires
C, 50.83; H, 3.41; N, 11.85; S, 27.13%; mmax(KBr)/cm−1 3055,
3004, 2959, 2920, 2849, 1686, 1503, 1498, 1360, 1332, 1288,
1203, 1060 and 1018;1H-NMR (300 MHz, DMSO-d6): d 2.52 (s,
3H, CH3), 7.57 (m, 3H, H-3ꢀ/H-5ꢀ, H-4ꢀ), 7.69 (dd, J = 8.2 Hz,
1.5 Hz, 2H, H-2ꢀ/H-6ꢀ); 13C-NMR (75 MHz, DMSO-d6): d 26.0
Crystal data. C11 H10 N2 O2 S, M = 234.27, monoclinic,
˚
a = 11.9376(16), b = 14.0036(19), c = 13.9101(19) A, b =
107.916(2)◦, Dcalcd = 1.407 g cm , U = 2212.6(5) A , T = 203(2)
K, space group P21/c, Z = 8, l(Mo–Ka) = 0.278 mm−1, 27 847
reflections measured (2hmax = 56.52◦), 5545 unique [Rint (F2) =
0.0279] which were used in all calculations. The final R1 was
−3
3
˚
0.0388 (Fo > 4r(F), 4467 data, 289 parameters), and wR2 (F2) =
−3
˚
0.1141 (all data), maximum residual electron density 0.39 e A .
Hydrogen atoms were placed in calculated positions and treated
as riding groups, with the 1.2 fold (1.5 fold for methyl groups)
isotropic displacement parameters of the equivalent Uij of the
corresponding carbon atom.
With two independent molecules, one has close O · · · S
ꢀ
˚
contacts via the inversion centres (O3–S21 2.925 A, C22–
O3–S21ꢀ 140.6◦), while the other does not exhibit significant
intermolecular contacts. The heterocycles adopt almost planar
conformations, the interplanar angles are 22.2 and 24.9◦,
respectively, for (S1, C2, N3, N4, C5)/(C8–C13) and (S21, C22,
N23, N24, C25)/(C28–C33). However, the torsion direction
is reversed as evident by the torsion angles N4–N3–C8–C9
−158.4◦ and N24–N23–C28–C29 156.1◦ as demonstrated by
the graphical overlay of both independent molecules (Fig. 2),
where the heterocycles are fitted best to each other.
(CH3), 126.9 (C-2ꢀ/C-6ꢀ), 129.8 (C-3ꢀ/C-5ꢀ), 130.4 (C-4ꢀ), 138.4
ꢀ
=
=
(C-1 ), 156.3 (C-5), 188.9 (C(2) S), 189.1 (Me–C O); HRMS
(EI): found 236.003228 (M+), C10H8N2OS2 requires 236.007792;
m/z (EI): 236 (M+, 64%), 235 (27), 193 (3), 160 (9), 135 (48), 118
(57), 91 (100) and 77 (64).
5-Acetyl-3-(4-methylphenyl)-1,3,4-thiadiazol-2(3H)-thione 8b
Crystallographic data for the structural analysis of 7b have
been deposited with the Cambridge Crystallographic Data
Center under the depository No. CCDC-260037. Copies of
information may be obtained free of charge from the Di-
rector, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK
(Fax: +44-1223-336033; e-mail: (deposit@ccdc.cam.ac.uk or
http://www.ccdc.cam.ac.uk).†
This compound was prepared from 6b (2.8 g, 10 mmol) and
1,1ꢀ-thiocarbonyldiimidazole (2.2 g, 12.5 mmol) by following
the same procedure described above for 8a. Yield 1.53 g (61%);
mp 76–77 ◦C; found C, 52.46; H, 3.88; N, 11.05; S, 25.36%.
C11H10N2OS2 requires C, 52.78; H, 4.03; N, 11.19; S, 25.61%;
mmax(KBr)/cm−1 3056, 3023, 2997, 2965, 2920, 2856, 1696, 1486,
1358, 1274, 1204, 1056 and 1017; 1H-NMR (300 MHz, DMSO-
d6): d 2.36 (s, 3H, CH3–Ar), 2.52 (s, 3H, CH3–CO), 7.36 (d, J =
8.2 Hz, 2H, H-3ꢀ/H-5ꢀ), 7.55 (d, J = 8.2 Hz, 2H, H-2ꢀ/H-6ꢀ); 13C-
NMR (75 MHz, DMSO-d6): d 21.3 (CH3–Ar), 26.0 (CH3CO),
126.6 (C-2ꢀ/C-6ꢀ), 130.2 (C-3ꢀ/C-5ꢀ), 136.0 (C-1ꢀ), 140.2 (C-4ꢀ),
† CCDC reference numbers 260037. See http://www.rsc.org/suppdata/
ob/b5/b505010c/ for crystallographic data in CIF or other electronic
format.
2 6 0 2
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 2 5 9 9 – 2 6 0 3